Targeted Reprogramming of Vitamin B3 Metabolism as a Nanotherapeutic Strategy towards Chemoresistant Cancers 【IF: 29.4】Adv Mater. 2023 Jun 1;e2301257 Sulforaphane purchased from AbMole
Lactate modulates iron metabolism by binding soluble adenylyl cyclase 【IF: 29】Cell Metab. 2023 Jul 18;S1550-4131(23)00227-9 Bithionol purchased from AbMole
A subpopulation of CD146+ macrophages enhances antitumor immunity by activating the NLRP3 inflammasome 【IF: 24.1】Cell Mol Immunol. 2023 Jun 12 (R)-(+)-BAY K 8644 purchased from AbMole
Single cell landscape of parietal epithelial cells in healthy and diseased states 【IF: 19.6】Kidney Int. 2023 Jul;104(1):108-123 BLZ945 (Sotuletinib) purchased from AbMole
Bioinspired Mild Photothermal Effect-Reinforced Multifunctional Fiber Scaffolds Promote Bone Regeneration 【IF: 18.027】ACS Nano. 2023 Mar 30 Vancomycin HCl purchased from AbMole
BRD9-mediated chromatin remodeling suppresses osteoclastogenesis through negative feedback mechanism 【IF: 17.694】Nat Commun. 2023 Mar 14;14(1):1413 (+)-JQ1 purchased from AbMole
Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field 【IF: 17.694】Nat Commun. 2023 Mar 23;14(1):1606 Ionomycin (Calcium salt) purchased from AbMole
Local H2 release remodels senescence microenvironment for improved repair of injured bone 【IF: 17.6】Nat Commun. 2023 Nov 27;14(1):7783 INCB18424 purchased from AbMole
Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma 【IF: 17.6】Nat Commun. 2023 May 27;14(1):3074 Y-27632 dihydrochloride purchased from AbMole
Temporal morphogen gradient-driven neural induction shapes single expanded neuroepithelium brain organoids with enhanced cortical identity 【IF: 17.6】Nat Commun. 2023 Nov 28;14(1):7361 Y-27632 dihydrochloride purchased from AbMole
ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis 【IF: 17.6】Nat Commun. 2023 Jul 13;14(1):4193 Y-27632 dihydrochloride purchased from AbMole
Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia 【IF: 17.521】Adv Sci (Weinh). 2023 Jan;10(2):e2201724 FB23-2 purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.